PetMed Express Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	21.41	54.72	55.3	104.09	111.08
Cash & Short-Term Investments	21.41	54.72	55.3	104.09	111.08
Cash Growth	-60.87%	-1.04%	-46.88%	-6.30%	-
Accounts Receivable	1.91	2.32	3.28	1.74	1.91
Inventory	13.61	16.21	28.56	19.02	32.46
Other Current Assets	6.64	5.63	6.51	5.58	5.55
Total Current Assets	43.56	78.87	93.65	130.43	151
Net Property, Plant & Equipment	26.84	29.83	28.09	26.18	24.46
Other Intangible Assets	10.79	13.35	16.5	5.86	0.86
Goodwill	-	26.66	26.66	-	-
Other Long-Term Assets	-	-	4.99	5.01	3.38
Total Assets	81.19	148.7	169.88	167.48	179.7
Accounts Payable	20.91	23.56	37.02	25.21	27.5
Accrued Expenses	29.93	36.58	32.07	32.3	28.75
Current Portion of Leases	0.49	0.46	0.46	-	-
Unearned Revenue	0.69	2.09	2.6	-	-
Other Current Liabilities	0.02	0.08	-	-	-
Total Current Liabilities	52.03	62.77	72.16	57.51	56.25
Long-Term Leases	0.04	0.54	1	-	-
Other Long-Term Liabilities	0.18	0.26	-	-	-
Total Long-Term Liabilities	0.22	0.8	1	-	-
Total Liabilities	52.25	63.57	73.15	57.51	56.25
Preferred Stock	0.01	0.01	0.01	0.01	0.01
Common Stock	0.02	0.02	0.02	0.02	0.02
Additional Paid-in Capital	19.65	18.56	25.15	18.28	11.66
Retained Earnings	9.26	66.54	71.56	91.66	111.76
Shareholders' Equity	28.94	85.13	96.73	109.97	123.45
Total Liabilities & Equity	81.19	148.7	169.88	167.48	179.7
Total Debt	0.54	1	1.45	0	0
Net Cash (Debt)	20.88	53.72	53.84	104.09	111.08
Net Cash Growth	-61.14%	-0.22%	-48.27%	-6.30%	-
Net Cash Per Share	1.00	2.61	2.64	5.12	5.46
Book Value	28.94	85.13	96.73	109.97	123.45
Book Value Per Share	1.38	4.13	4.74	5.41	6.06
Tangible Book Value	18.15	45.13	53.57	104.11	122.59
Tangible Book Value Per Share	0.87	2.19	2.63	5.12	6.02

SEC Filings: 10-K · 10-Q